myDNA Pharmacogenomics Mental Health Medication Test
Pharmacogenomics (PGx) is the study of how genetic variations influence the way an individual responds to medications. PGx enables doctors to test for specific genetic changes to predict whether a patient may have a normal response, a poor response or a higher risk of side effects, before prescribing a specific medication.
doctor holding pills iscreen

This DNA test helps you discover your response to certain mental health medications, including antidepressants and antipsychotics. The test identifies common genetic variations in the genes encoding drug metabolising enzymes (e.g. Cytochrome P450 enzymes), which can result in changes to the activity of these enzymes. For example, for an intermediate or poor metaboliser, reduced metabolism results in increased plasma concentrations of the substrate medication. This can lead to an increased risk of side effects and toxicity from standard doses. Alternatively, a rapid or ultrarapid metaboliser, with overly efficient elimination of the substrate medication results in reduced plasma concentrations. This can lead to less medication being available for clinical effect, and potentially therapeutic failure.

What we test
MyDNA Mental Health Pharmacogenomic Report
Test instructions
Your test kit and all instructions are posted directly to you, and there is no need to visit a collection centre.
Mail your sample back to the lab using the prepaid envelope and packaging.
calendar-instructions instruction-kit
Results for this test available in 2 weeks from being received and will be published in your online dashboard.
Ready. Set. Go!
for £170